Office of Research & Development |
|
Project Number: | I01CX002060-01A2 |
| Title: | Immunogenicity of recombinant zoster vaccine in Rheumatoid arthritis patients |
| Principal Investigator: | David Canaday |
| Location: | Cleveland, OH |
| Congressional District Code: | 11 |
| Research Service: | Clinical Science R&D |
| Project Period: | July 2021 - June 2024 |
| FY 2023 Funding Amount: | $266,825 |
| Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |